AAPS PharmSci 5 , 2728 (2003)
Ct S, Zhou D, Bianchini A, Nervi C, Gallagher RE, Miller Jr WH
Andreeff M , Beck JD, Kapoor N, Steinmetz J, Melamed MR, Gee T, Miller D, Clarkson B
Recalls & Warnings August 09, 2012 FDA Warns Sports Nutrition Manufacturer of GMP Violations On June 26, 2012, the FDA issued a warning letter to Parrillo Performance subsequent to a manufacturing and packing facility inspection which found Parrillo products to be adulterated due to current Good Manufacturing Practices (cGMP) violations
Patients are advised to avoid anti-inflammatory medications around the time of injections to allow the intended inflammatory-healing process to occur
Single-cell transcriptome analysis of Bisphenol A exposure reveals the key roles of the testicular microenvironment in male reproduction